Real-World Safety and Efficacy of Sacituzumab Govitecan in Patients With Metastatic TNBC in the UK
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom
Br. J. Cancer 2024 Apr 24;[EPub Ahead of Print], D Hanna, S Merrick, A Ghose, MJ Devlin, DD Yang, E Phillips, A Okines, N Chopra, E Papadimatraki, K Ross, I Macpherson, ZY Boh, CO Michie, A Swampillai, S Gupta, T Robinson, L Germain, C Twelves, C Atkinson, A Konstantis, P Riddle, N Cresti, JD Naik, A Borley, A Guppy, P Schmid, M PhillipsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.